tirzepatide for metabolic dysfunction Dysfunction–Associated Steatohepatitis (MASH) & Uptick in GLP1 Use VisualAbstract: Tirzepatide for Metabolic Dysfunction-Associated

Enhanced glycemic control helps reduce diabetes-related complications, making this medication especially beneficial for overweight or obese patients with type 2 diabetes or prediabetes under the care of Primary Care of Clear Lake

The starting doses of these medications are different

However, services like GoodRx can help patients find lower prices and coupons, making prescriptions more affordable

Is this medication a lifelong commitment

The glucagon component is especially relevant for liver fat

7 Subcutaneous semaglutide was approved in 2021 and 2022 as Wegovy for weight loss in patients 12 and older after the STEP1 trial showed patients who took subcutaneous semaglutide had a -14.9% body weight reduction (-15.3kg) compared to -2.4% (-2.6kg) with placebo after 68 weeks